- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03570008
Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program (ThermOs)
Osteoporosis is an increasing public health problem. Involution of bone mass in women is due to a reduction in sensitivity of the bone to the mechanical stress due to the slow-down of the bone turnover after 35 years old. Osteoporosis is a silent disease combining a decrease in bone mass (quantity) and an impaired bone microarchitecture (quality) leading to an increased risk of fracture. Bone microarchitecture is an important element to be taken into account in assessing the bone properties, as demonstrated by numerous ex vivo studies.
Bone densitometry only identifies 50% of osteoporotic fractures. The other half of the fractures appears in osteopenic women. The measurement of bone mineral density is too limited to assess risk of fracture. Bone microarchitecture can be assessed through a peripheral quantitative computed tomography scan (computed tomography peripherical - pQCT). The microarchitecture data allow the calculation of bone strength index (BSI) and stress strength index (SSI) highly predictive of fracture risk. These qualitative determinants of bone fragility are the most relevant to evaluate effect of physical activity over a short period compared with bone mineral content and density, which requires several months of constraints. Biochemical markers of bone turnover, specifically those of bone resorption, are predictive of the risk of osteoporotic fracture.
Physical activity can reduce the risk of fracture up to 20-35% via direct effects on bone strength, at any age. However, response of bone varies with modalities of exercise. Repeated exercise produces greater bone adaptations than a single bout. Moreover, it has been well demonstrated since 1970 that bone responds to a dynamic stimulation, but not a static stimulation, with a dose response relationship. It has been confirmed in premenopausal women.
The effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular) has not been investigated in primary prevention. This original study would highlight the effect of short-term specific physical activity on the prevention of bone fragility (qualitative) observed with age in premenopausal women.
The main hypothesis is that a spa residential program including physical activity will have greater benefits on bone cortical porosity than a spa residential program alone or physical activity alone, in premenopausal women.
Study Overview
Status
Conditions
Detailed Description
The ThermOs protocol was designed to provide a better understanding of the effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular), in prevention of bone fragility among premenopausal women.
In the present protocol, parameters are measured on four occasions (baseline, 10 days, at 6 months and at 12 months).
Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p<0.05 will be considered significant. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions.
Inter-groups comparisons will systematically be performed 1) without adjustment and 2) adjusting on factors liable to be biased between groups.
Analysis will be performed using anova or Kruskal-Wallis (KW) tests. When appropriate (p<0.05), a post-hoc test for multiple comparisons (Tukey-Kramer after anova and Dunn post KW) will be used. Linear regression (with logarithmic transformation if necessary) considering an adjustment on covariates fixed according to epidemiological relevance and observance to physical activity will complete the analysis. Relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman) and compared with Chi-squared or Fischer test. Longitudinal data will be treated using mixt-model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- CHU Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women with regular cycles
- 40-50 years old
- Sedentary lifestyle
- stable body weight over the previous 6 months
- Normal weighted (BMI<30)
- written informed consent.
- Affiliated to French health care system (for France)
Exclusion Criteria:
- Menopausal women
- Regular physical activity > 4 hours / week of moderate or high intensities
- Participant refusal to participate
- Hepatic, renal, or psychiatric diseases, nor cardiovascular or endocrine diseases (thyroid diseases will be included)
- HIV infection
- Use of medications altering body weight, corticosteroids, Nonsteroidal anti-inflammatory drugs
- Use of medications influencing bone parameters such as bisphosphonate, other osteoporotic treatment therapy, or chemotherapy
- Regular alcohol consumption (>20g of alcohol per day)
- Restricted diet over the previous 6 months
- Deficit or supplementation in vitamin D
- Protected persons are not excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sp-Ex
a 9 days spa residential program including physical activity.
3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity.
Participants will benefit advices from national plan for physical activity and nutrition (NPPN)
|
After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants:
After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts. After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants:
After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts. |
Active Comparator: Sp-alone
Participants will benefit a short term spa residential program of 9 days.
In addition they will benefit advices from national plan for physical activity and nutrition (NPPN)
|
After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants:
After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts. |
Active Comparator: Ex-alone
Participants will benefit 3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity.
Participants will benefit advices from national plan for physical activity and nutrition (NPPN)
|
After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants:
After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variation of bone cortical porosity in premenopausal women after the interventional phase.
Time Frame: at Baseline
|
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
|
at Baseline
|
Variation of bone cortical porosity in premenopausal women
Time Frame: after 10 days
|
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
|
after 10 days
|
Variation of bone cortical porosity in premenopausal women
Time Frame: after 6 months
|
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
|
after 6 months
|
Variation of bone cortical porosity in premenopausal women
Time Frame: after 12 months
|
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
|
after 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
bone fracture risk
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
questionnaire (FRAX - Fracture Risk Assessment Tool, bone fracture risks ; after registering results from DXA and personal details the computer calculates the fracture risks based on an algorithm)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
General Health
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
General Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Greater short-term benefits on health factors with the Sp-Ex program than with Sp-alone or Ex-alone (Bone health will be obtained from the combination of 5 measures).
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Evaluate the effectiveness of the Sp-Ex program compared with the Sp-alone or Ex-alone on short-term modification of health factors among premenopausal women.
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Physical Activity
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Quality of life will be measured using the SF-36 (Short Form 36 ; 9 sections questionnaire ; scale range from 0 (bad) to 100(excellent))
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Quality of life
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Calcium intake will be measured using the Fardellonne questionnaire (recommended daily consummation in France: women 900 mg/d; women >55 years old 1200mg/d)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Calcium intake
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Depression and anxiety will be measured using Hamilton scale (scale range from 0 to 4, if > 20 high level of anxiety)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Depression and anxiety
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Depression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Depression and anxiety
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
anxiety will be measured using the state and trait anxiety inventory scale (scale range from 1 to 4, with a total score between 20 to 80.
If <35 poor level of anxiety, if > 66 very high level of anxiety)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Anxiety
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Burn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Burn-out
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Job content
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Body mass
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Body mass (muscle and fat) will be measured using Impedancemeter
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Anthropometry
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
weight (kg) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Anthropometry
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
height (m) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Anthropometry
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
waist circumference (cm) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Basic biology
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
HbA1c (mmol/mol) will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Basic biology
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
HDLc (mmol/L) will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Basic biology
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
LDL-cholesterol (mmol/L) will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Basic biology
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Triglyceride (TG-mmol/L) will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Vitamin D
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Vitamin D will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Leptin
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Leptin will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Pro-inflammatory cytokine
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
Pro-inflammatory cytokine (IL-1β, IL-6, IL-1, TNFα, IFNγ) will be measured using endocrine assays
|
at Baseline, after 10 days, after 6 months, after 12 months
|
heart rate variability
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
heart rate variability will be measured using Holter
|
at Baseline, after 10 days, after 6 months, after 12 months
|
electrodermal activity
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
electrodermal activity (skin conductance) will be measured using Wirst band electrodes
|
at Baseline, after 10 days, after 6 months, after 12 months
|
physical activity behaviour
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
physical activity behaviour will be measured using an activity journal (participant will have to write all their daily activity from when they wake up to when they go to bed)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
physical activity behaviour
Time Frame: at Baseline, after 10 days, after 6 months, after 12 months
|
will be measured using an accelerometer-pedometer watch (daily step count)
|
at Baseline, after 10 days, after 6 months, after 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-387
- 2016-A02083-48 (Other Identifier: 2016-A02083-48)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporotic Fracture
-
Jiawei JiangRecruitingOsteoporotic Fracture of VertebraChina
-
Assiut UniversityUnknownOsteoporotic Fracture of Vertebra
-
Nexilis AGTerminatedOsteoporotic Fracture of VertebraAustria
-
Shenzhen People's HospitalCompletedOsteoporotic Vertebral Compression FractureChina
-
Assistance Publique - Hôpitaux de ParisHospices Civils de LyonActive, not recruitingSevere Fragility FractureFrance
-
Suzhou Municipal HospitalRecruiting
-
Groupe Hospitalier Paris Saint JosephHôpital Sainte-Marie ParisActive, not recruitingOsteoporotic FracturesFrance
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
Wiltrom Co., Ltd.Maxis Medical GmbHRecruitingOsteoporotic Vertebral Compression FracturesGermany
-
Inbo HanEnrolling by invitationOsteoporotic Fractures | Vertebral Compression FractureKorea, Republic of
Clinical Trials on 9 days spa residential program
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; European Regional Development Fund; Regional Council of... and other collaboratorsUnknownStress | Burn Out | Heart Rate VariabilityFrance
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; European Regional Development Fund; Regional Council of... and other collaboratorsUnknownObesity | StressFrance
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; LaPEC laboratory (EA 4278), University of Avignon, Avignon... and other collaboratorsUnknown
-
University of CopenhagenKU Leuven; University of Minnesota; Technical University of DenmarkCompletedDiet, Healthy | Metabolic DiseaseDenmark
-
Association Francaise pour la Recherche ThermaleUnknown
-
Assistance Publique - Hôpitaux de ParisAssociation Francaise pour la Recherche ThermaleCompleted
-
McMaster UniversityAlberta Health services; Saskatchewan Health Authority - Regina Area; Canadian... and other collaboratorsActive, not recruitingFrail Elderly SyndromeCanada
-
Soroka University Medical CenterUnknownTraumatic Brain Injury | Cerebral Infarction | Cerebral Hemorrhage | Aneurysmal Subarachnoid HemorrhageGermany, Israel
-
Association Francaise pour la Recherche ThermaleUniversity of Bordeaux; University Hospital, BordeauxRecruiting
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...CompletedPhysical Activity | Sleep | Overweight and Obesity | Feeding Behavior | Diet Habit | Social Determinants of Health